Jane Street
KPRX icon

Jane Street’s Kiora Pharmaceuticals KPRX Stock Holding History

Jane Street’s Portfolio KPRX Stock Details KPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.9K Buy
+10,615
New +$26.7K ﹤0.01% 11120
2022
Q1 		– Sell
-87
Closed -$47K – 10688
2021
Q4 		$47K Sell
87
-10
-10% -$5.64K ﹤0.01% 9554
2021
Q3 		$78K Buy
+97
New +$82.4K ﹤0.01% 9394
2018
Q4 		– Sell
-3
Closed -$5K – 5359
2018
Q3 		$5K Buy
+3
New +$8.06K ﹤0.01% 5002

Other funds holding KPRX

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SRL
Scientech Research LLC Jersey City, New Jersey $123M AUM 198.31% 1-Year Est. Return

Jane Street's KPRX Position: Q2 2026 in Review

Jane Street opened a new position in Kiora Pharmaceuticals (KPRX) in Q2 2026: 10,615 shares worth $27.9K. The stake represents ﹤0.01% of the portfolio and ranks #11120 among its holdings. This is a return to the name: Jane Street previously reported a position in KPRX as recently as Q4 2021.

Jane Street first reported a position in KPRX in Q3 2018 and has held it in 4 quarters since. The position peaked at $78K in Q3 2021. 22 funds tracked by Wall St. Rank hold KPRX as of Q2 2026.

  • Jane Street held 10,615 shares of Kiora Pharmaceuticals worth $27.9K as of Q2 2026.
  • Kiora Pharmaceuticals was a new Jane Street position in Q2 2026.
  • Kiora Pharmaceuticals made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #11120 holding.
  • Jane Street first reported a position in Kiora Pharmaceuticals in Q3 2018 and has held it in 4 quarters since.
  • Jane Street's Kiora Pharmaceuticals position peaked at $78K in Q3 2021.
  • 22 funds tracked by Wall St. Rank held Kiora Pharmaceuticals as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.